Bulk Inquiry
LIMK1 inhibitor BMS4
- BMS4
Axon 1949
CAS:
905298-84-2
Purity:
99%
- Soluble in DMSO
- MF: C23H23N7O2S
- MW: 461.54
Description
LIMK1 inhibitor BMS4 is a potent LIM kinase 1 (LIMK1) inhibitor with reported IC50 activity of 22 nM. It inhibits LIMK1-dependent regulation of cofilin phosphorylation and actin cytoskeletal dynamics.
LIMK1 controls actin remodeling downstream of Rho-family GTPase pathways and is involved in cell motility, invasion and morphogenesis. LIMK1 inhibitor BMS4 is useful for studying cytoskeletal signaling and migration-related pharmacology.
Key Features
- Potent LIMK1 inhibitor
- Reported IC50: 22 nM
- Modulates cofilin and actin cytoskeleton regulation
- Reported to lack off-target cytotoxic effects in source assays
Applications
- Actin cytoskeleton research
- Cell migration and invasion assays
- LIMK/cofilin pathway studies
- Cancer cell motility pharmacology
More Information
| Parent CAS No. | 905298-84-2 |
|---|---|
| Chemical Name | 1-ethyl-3-(5-(6-(4-methoxy-2,6-dimethylphenyl)-2-(pyrazin-2-yl)pyrimidin-4-yl)thiazol-2-yl)urea |
| SMILES | N(CC)C(NC1=NC=C(C2C=C(C3=C(C)C=C(OC)C=C3C)N=C(C3=NC=CN=C3)N=2)S1)=O |
| MFCD | N.A. |
| InChi | InChI=1S/C23H23N7O2S/c1-5-25-22(31)30-23-27-12-19(33-23)16-10-17(20-13(2)8-15(32-4)9-14(20)3)29-21(28-16)18-11-24-6-7-26-18/h6-12H,5H2,1-4H3,(H2,25,27,30,31) |
| InChiKey | WUCYRTXFXRZKSV-UHFFFAOYSA-N |
| CID | 46192505 |
| Short Description | LIMK1 inhibitor |
LIMK1 inhibitor BMS4
potent LIMK1 inhibitor
BMS-4
LIMK1inhibitorBMS4
BMS 4
LIMK1
Inhibitor
Actin cytoskeleton research
Cell migration and invasion assays
LIMK/cofilin pathway studies
Cancer cell motility pharmacology
cancer biology
kinase signaling
signal transduction
developmental biology
drug discovery
enzyme pharmacology
CAS 905298-84-2
Axon Medchem
Axon 1949
Supplier
Vendor
Other Categories
Get a Quote for
Loading...


